P709-1240 Screening compound: 1-[5-(3-tert-butyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide

P709-1240 Screening compound: 1-[5-(3-tert-butyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide
P709-1240 Screening compound: 1-[5-(3-tert-butyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P709-1240
1-[5-(3-tert-butyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P709-1240

Molecular Formula

C21H26N6O3 (C21 H26 N6 O3)

Compound Name

1-[5-(3-tert-butyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide

IUPAC name

1-[5-(3-tert-butyl-124-oxadiazol-5-yl)pyridin-2-yl]-5-methyl-N-[(oxolan-2-yl)methyl]-1H-pyrazole-4-carboxamide

SMILES

CC(C)(C)c1noc(-c(cc2)cnc2-n2ncc(C(NCC3OCCC3)=O)c2C)n1

InChI

InChI=1S/C21H26N6O3/c1-13-16(18(28)23-11-15-6-5-9-29-15)12-24-27(13)17-8-7-14(10-22-17)19-25-20(26-30-19)21(2,3)4/h7-8,10,12,15H,5-6,9,11H2,1-4H3,(H,23,28)/t15-/m1/s1

InChI Key

QNZXMETVGAFBAK-OAHLLOKOSA-N

MDL Number (MFCD)

MFCD27613488

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.181

Distribution Coefficient, logD

3.179

Water Solubility, LogSw

-3.31

Polar Surface Area

87.649

Acid Dissociation Constant (pKa)

13.02

Base Dissociation Constant (pKb)

5.08

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.60

P709-1240 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P709-1240 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P709-1240?
Check Price and Availability of P709-1240, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P709-1240 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P709-1240
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P709-1240
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P709-1240 available by request